The American journal of gastroenterology · 2024
Older Adults With Celiac Disease Are At Increased Risk of Frailty: A Nationwide Cohort Study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zylberberg Haley M, Lebwohl Benjamin, Söderling Jonas, Kochar Bharati, Jylhävä Juulia, Green Peter H R, Ludvigsson Jonas F
Аннотация
INTRODUCTION: Celiac disease (CeD) is increasingly diagnosed in older adults, though few studies have explored complications in this group. As frailty confers increased risk for adverse events, we aimed to explore frailty in older adults with CeD.
METHODS: In a nationwide Swedish cohort, we identified adults ≥60 years with incident CeD between 2004 and 2017 which we matched to population-based controls without CeD by age, sex, county, and calendar-period. Baseline frailty within 3 years before CeD diagnosis or index date was assessed using the Hospital Frailty Risk Score. Among those without baseline frailty, we used conditional logistic regression to estimate odds ratios and 95% confidence intervals of future frailty at 5 years comparing CeD with controls. Logistic regression was used to evaluate the association between persistent villous atrophy vs mucosal healing and frailty in patients with CeD.
RESULTS: A total of 4,646 older adults with CeD were matched to 21,944 non-CeD individuals. Baseline frailty was increased in patients with CeD (54.4%) compared with controls (29.7%, P < 0.001), which existed across all frailty categories: low-risk (43.4% vs 23.8%), intermediate-risk (10.3% vs 5.4%), and high-risk (0.8% vs 0.6%). Among those without baseline frailty, patients with CeD had a 61% increased risk of overall frailty at 5 years (95% confidence interval 1.46-1.78). Mucosal healing in CeD individuals on follow-up biopsy did not protect against future frailty.
DISCUSSION: Older adults with CeD were significantly more likely to become frail than matched comparators. This analysis reveals the increased vulnerability that older patients with CeD are likely to experience.
METHODS: In a nationwide Swedish cohort, we identified adults ≥60 years with incident CeD between 2004 and 2017 which we matched to population-based controls without CeD by age, sex, county, and calendar-period. Baseline frailty within 3 years before CeD diagnosis or index date was assessed using the Hospital Frailty Risk Score. Among those without baseline frailty, we used conditional logistic regression to estimate odds ratios and 95% confidence intervals of future frailty at 5 years comparing CeD with controls. Logistic regression was used to evaluate the association between persistent villous atrophy vs mucosal healing and frailty in patients with CeD.
RESULTS: A total of 4,646 older adults with CeD were matched to 21,944 non-CeD individuals. Baseline frailty was increased in patients with CeD (54.4%) compared with controls (29.7%, P < 0.001), which existed across all frailty categories: low-risk (43.4% vs 23.8%), intermediate-risk (10.3% vs 5.4%), and high-risk (0.8% vs 0.6%). Among those without baseline frailty, patients with CeD had a 61% increased risk of overall frailty at 5 years (95% confidence interval 1.46-1.78). Mucosal healing in CeD individuals on follow-up biopsy did not protect against future frailty.
DISCUSSION: Older adults with CeD were significantly more likely to become frail than matched comparators. This analysis reveals the increased vulnerability that older patients with CeD are likely to experience.